Horizon Discovery today announces that it has appointed Dr Darrin M Disley, as its Executive Chairman. Dr Disley is a serial entrepreneur with the experience of setting-up seven new ventures in the Biotech, IT and Consumer Products markets and has a track-record for building sustainable businesses from low-tech and high-tech innovation.
Dr Disley holds a PhD in Biotechnology from the University of Cambridge; has been the author of six papers, 7 patent applications and 26 conference abstracts and; has been an advisor on biotech commercialisation strategies to key technology centres in Europe, USA, India and Africa.
He takes up his new post from 12th June 2009 following working in investor, board and various operational roles for Horizon since October 2007; and will be responsible for supporting the CEO, Dr Chris Torrance in growing Horizon Discovery’s core products and services business and overseeing the set-up of new business units / new ventures that address unmet needs in the companion diagnostics; bio-production and oncology discovery and development fields.
Dr Disley says “I am looking forward to ensuring that Horizon Discovery builds on a stellar early-stage business performance. As an entrepreneur, I can appreciate a business model which leverages a world-class academic heritage; early products and revenues to build a profitable head-line business and then take equity positions in ventures that address additional valuable markets to build investor value. It is a very exciting time to be working with such talented, socially-aware and dedicated team of founders, scientists and investors”.